< Back to search
Filter
1
Active & ResponsiveNew

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Atlanta GA, Portland OR, Duarte CA, Palo Alto CA
Sponsor: Kelonia Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07075185

Phase1, Recruiting
Active & Responsive

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

for
Amyotrophic Lateral Sclerosis
Location: Philadelphia PA, Columbus OH, Columbia MO
Sponsor: Insmed Gene Therapy LLC

Sex: All

Age: 18 - 70+

Code: NCT07290062

Phase1, Recruiting
Active & Responsive

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

for
Rett Syndrome
Location: Boston MA, New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Neurogene Inc.

Sex: Female

Age: 3+

Code: NCT05898620

Phase3, Recruiting
Active & Responsive

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

for
Friedreich Ataxia, Cardiomyopathies, Cardiac Hypertrophy,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 12 - 50

Code: NCT05302271

Phase1, Recruiting
Active & ResponsiveNew

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: Fairfax VA, Durham NC, Dallas TX
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase3, Recruiting

Interested in new gene therapy trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

for
Muscular Atrophy, Spinal
Location: Philadelphia PA, Norfolk VA, Gainesville FL, Atlanta GA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 2

Code: NCT05861999

Recruiting
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Boston MA, New York NY, Orlando FL, Jacksonville FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 17

Code: NCT05788536

Phase1, Phase2, Recruiting
Active & Responsive

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

for
Mesial Temporal Lobe Epilepsy
Location: Boston MA, Lebanon NH, Hackensack NJ, New Brunswick NJ,
Sponsor: UniQure Biopharma B.V.

Sex: All

Age: 18 - 70+

Code: NCT06063850

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

for
Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal
Location: Toronto, Columbus OH, Nashville TN, Houston TX
Sponsor: AviadoBio Ltd

Sex: All

Age: 30 - 70+

Code: NCT06064890

Phase1, Phase2, Recruiting
Active & Responsive

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

for
X-linked Retinoschisis
Location: Philadelphia PA, Miami FL, Portland OR, Los Angeles CA
Sponsor: Atsena Therapeutics Inc.

Sex: Male

Age: 6+

Code: NCT05878860

Phase1, Phase2, Recruiting